Last reviewed · How we verify
Platelet Rich Plasma Joint Injection
Platelet Rich Plasma Joint Injection is a Small molecule drug developed by Star Spine and Sport. It is currently FDA-approved. Also known as: PRP Joint Injection, PRP.
At a glance
| Generic name | Platelet Rich Plasma Joint Injection |
|---|---|
| Also known as | PRP Joint Injection, PRP |
| Sponsor | Star Spine and Sport |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial) (NA)
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage. (PHASE2)
- Intra-articular Platelet-Rich Plasma for Acetabular Labral Tears (NA)
- Efficacy of Therapy With PRP Injections Versus HA in Patients With Advanced Grade of GONArthrosis (NA)
- Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder (NA)
- Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and Without Intra-articular Platelet-Rich Plasma Injection. (PHASE2)
- Arthrocentesis of Temporomandibular Joint Using Ozonated Water Alongside With Platelet Rich Plasma Injection in Management of Anterior Disc Displacement Without Reduction: (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Platelet Rich Plasma Joint Injection CI brief — competitive landscape report
- Platelet Rich Plasma Joint Injection updates RSS · CI watch RSS
- Star Spine and Sport portfolio CI
Frequently asked questions about Platelet Rich Plasma Joint Injection
What is Platelet Rich Plasma Joint Injection?
Platelet Rich Plasma Joint Injection is a Small molecule drug developed by Star Spine and Sport.
Who makes Platelet Rich Plasma Joint Injection?
Platelet Rich Plasma Joint Injection is developed and marketed by Star Spine and Sport (see full Star Spine and Sport pipeline at /company/star-spine-and-sport).
Is Platelet Rich Plasma Joint Injection also known as anything else?
Platelet Rich Plasma Joint Injection is also known as PRP Joint Injection, PRP.
What development phase is Platelet Rich Plasma Joint Injection in?
Platelet Rich Plasma Joint Injection is FDA-approved (marketed).
Related
- Manufacturer: Star Spine and Sport — full pipeline
- Also known as: PRP Joint Injection, PRP
- Compare: Platelet Rich Plasma Joint Injection vs similar drugs
- Pricing: Platelet Rich Plasma Joint Injection cost, discount & access